Senior insider sale
Chief Financial Officer at CADRENAL THERAPEUTICS, INC. — senior position signals high conviction
$198.3K
18.83K shares
What this filing means
SZOT MATTHEW K plans to sell 18.83K shares of CADRENAL THERAPEUTICS, INC. valued at approximately $198.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/29/2025ACC: 0001950047-25-010733
Officer· Chief Financial Officer
Since Jan 2023
18.83K
Shares to sell
$198.3K
Approx. market value
9.93K
Acquired (3 months)
1
Planned
6 completed
Securities Acquired — Last 3 Months1
Founders Shares
N/A
5/17/2022
9.93KTotal acquired9.93K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/17/2022 | Founders Shares N/A | 9.93K | — |
| Total | 9.93K | ||
Planned & Completed Dispositions7
Completed
—Completed
Units to sell
1.80K
Market value
$25.2K
10/27/2025
—Completed
Units to sell
1.80K
Market value
$25.2K
10/24/2025
—Completed
Units to sell
1.80K
Market value
$25.3K
10/13/2025
—Completed
Units to sell
1.69K
Market value
$23.7K
10/9/2025
—Completed
Units to sell
107.00
Market value
$1.5K
10/6/2025
—Completed
Units to sell
1.70K
Market value
$23.8K
10/1/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
9.93K
Market value
$73.6K
12/29/2025
Total
Units
18.83K
Value
$198.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/27/2025 | 1.80K | $25.2K | — | Completed |
10/24/2025 | 1.80K | $25.2K | — | Completed |
10/13/2025 | 1.80K | $25.3K | — | Completed |
10/9/2025 | 1.69K | $23.7K | — | Completed |
10/6/2025 | 107.00 | $1.5K | — | Completed |
10/1/2025 | 1.70K | $23.8K | — | Completed |
| Planned — Approximate Date | ||||
12/29/2025 | 9.93K | $73.6K | NASDAQ | Planned |
| Total | 18.83K | $198.3K | ||